Effects of GLP-1 receptor agonists on arrhythmias and its subtypes in patients with type 2 diabetes: A systematic review and meta-analysis
PurposeAn update of a systematic review and meta-analysis of the risk of arrhythmias and their subtypes in type 2 diabetic patients receiving glucagon-like peptide 1 receptor agonist (GLP-1RA) medication according to data from the Cardiovascular Outcome Trial(CVOT).MethodsRandomized controlled trial...
Autori principali: | , , , , , |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
Frontiers Media S.A.
2022-08-01
|
Serie: | Frontiers in Endocrinology |
Soggetti: | |
Accesso online: | https://www.frontiersin.org/articles/10.3389/fendo.2022.910256/full |